A gene set enrichment analysis for cancer hallmarks
Journal of Pharmaceutical Analysis · 2025-05 · 15 (5) · 101065
DOI: 10.1016/j.jpha.2024.101065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2025-05. Verfasst von Otília Menyhart und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biomarker Research Group, Institute of Molecular Life Sciences, Hungarian Research Network, Budapest, 1117, Hungary. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nemzeti Kutatási Fejlesztési és Innovációs Hivatal, Hungarian Academy of Sciences, Hungarian Scientific Research Fund.
Abstract (Originalsprache)
The "hallmarks of cancer" concept provides a valuable framework for understanding fundamental organizing principles common to various cancers. However, without a consensus gene set for cancer hallmarks, data comparison and integration result in diverse biological interpretations across studies. Therefore, we aimed to form a consensus cancer hallmark gene set by merging data from available mapping resources and establishing a framework for mining these gene sets. By consolidating data from seven projects, 6763 genes associated with 10 cancer hallmarks were identified. A cancer hallmarks enrichment analysis was performed for prognostic genes associated with overall survival across 12 types of solid tumors. "Tissue invasion and metastasis" was most prominent in cancers of the stomach (P = 2.2 × 10-11), pancreas (P = 4.2 × 10-9), bladder (P = 3.3 × 10-8), and ovaries (P = 0.0007), aligning with their heightened potential to spread. "Sustained angiogenesis" was most prominent in squamous cell carcinomas of the lung (P = 2.5 × 10-7), while "genome instability" showed strong enrichment in lung adenocarcinomas (LUADs) (P = 1.5 × 10-8) and cancers of the liver (P = 5.5 × 10-10), pancreas (P = 2.1 × 10-5), and kidney (P = 0.018). Pancreatic cancers displayed the highest enrichment of hallmarks, emphasizing the disease's complexity, while in melanomas and cancers of the liver, prostate, and kidney, a single hallmark was enriched among the prognostic markers of survival. Additionally, an online tool (www.cancerhallmarks.com) that allows the identification of cancer-associated hallmarks from new gene sets was established. In summary, our aim of establishing a consensus list of cancer hallmark genes was achieved. Furthermore, the analysis of survival-associated genes revealed a unique pattern of hallmark enrichment with potential pharmacological implications in different tumor types.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Biomarker Research Group, Institute of Molecular Life Sciences, Hungarian Research Network, Budapest, 1117, Hungary.
- National Laboratory for Drug Research and Development, Budapest, 1117, Hungary.
- Department of Bioinformatics, Semmelweis University, Budapest, 1094, Hungary.
- Department of Biophysics, Medical School, University of Pecs, Pecs, 7624, Hungary.
Förderung
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
- Hungarian Academy of Sciences
- Hungarian Scientific Research Fund
- National Research Development and Innovation Office
Zitieren
APA
Menyhart, O., Kothalawala, W. J., & Győrffy, B. (2025). A gene set enrichment analysis for cancer hallmarks. Journal of Pharmaceutical Analysis, 15(5), 101065. https://doi.org/10.1016/j.jpha.2024.101065
Vancouver
Menyhart O, Kothalawala WJ, Győrffy B. A gene set enrichment analysis for cancer hallmarks. Journal of Pharmaceutical Analysis. 2025;15(5):101065. doi:10.1016/j.jpha.2024.101065
BibTeX
@article{Menyhart2025,
author = {Menyhart, Otília and Kothalawala, William Jayasekara and Győrffy, Balázs},
title = {A gene set enrichment analysis for cancer hallmarks},
journal = {Journal of Pharmaceutical Analysis},
year = {2025},
volume = {15},
number = {5},
pages = {101065},
doi = {10.1016/j.jpha.2024.101065}
}
EUVIMED